In BC cell lines it was shown that the combination of Astemizole (Kv10.1 blocker) and gefitinib (EGFR inhibitor) have a synergic effect in impairing proliferation in BC cells expressing both proteins (García-Quiroz et al., 2019a). The gene discussed is KCNH1; the disease is breast cancer.